
Reset all filters
01 1Abbvie Ag
02 2Abbvie Deutschland Gmbh & Co Kg
03 2Abbvie Deutschland Gmbh & Co. Kg
Reset all filters
01 2Glecaprevir; Pibrentasvir
02 1Glecaprevir|Pibrentasvir
03 2Glekaprevir Pibrentasvir
Reset all filters
01 2Coated Granule In Sachet
02 3Film Coated Tablet
Reset all filters
01 2Spain
02 2Sweden
03 1Switzerland
Reset all filters
01 4Maviret
02 1Maviret Film-coated Tablets
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Maviret Film-coated Tablets
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 22/09/2017
Application Number : 66472
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Maviret
Dosage Form : Film Coated Tablet
Dosage Strength : 100mg;40mg
Packaging :
Approval Date : 26/07/2017
Application Number : 20161222000040
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Maviret
Dosage Form : Coated Granule In Sachet
Dosage Strength : 50mg/20mg
Packaging :
Approval Date : 21/06/2021
Application Number : 20200310000071
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Maviret
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG; 40 MG
Packaging :
Approval Date : 2017-08-03
Application Number : 1171213001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Maviret
Dosage Form : Coated Granule In Sachet
Dosage Strength : 50MG; 20 MG
Packaging :
Approval Date : 2021-12-23
Application Number : 1171213002
Regulatory Info : Authorized
Registration Country : Spain